Get started
AAREY DRUGS & PHARMACEUTICALSAAREY DRUGS & PHARMACEUTICALSAAREY DRUGS & PHARMACEUTICALS

AAREY DRUGS & PHARMACEUTICALS

No trades
See on Supercharts
Overview
Financials
News Ideas Discussions Technicals Seasonals

AAREYDRUGS fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Aarey Drugs & Pharmaceuticals Ltd. engages in the trade and manufacture of pharmaceutical ingredients, drug intermediates, specialty chemicals, industrial solvents, and chemicals. Its products include mono methyl urea, dimethyl urea, theobromine, theophylline, mefanamic acid, bromomethyl, and dioxolane. The company was founded by Rajesh Pranlal Ghatalia on May 15, 1990 and is headquartered in Mumbai, India.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

AAREYDRUGS does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company